A 25-year-old female was diagnosed to have pulmonary tuberculosis two years before and had received Anti-tubercular treatment (ATT) for the same. During her initial presentation, she had extra-foveal healed choroidal granulomas (CG) The mantoux test remained positive. The patient was restarted on ATT with additional oral steroid therapy. Due to poor response and steroid related side effects an intra-vitreal injection of bevacizumab was given to help in early resolution of exudation. Slow tapering of steroids was initiated. At 3 months follow up significant reduction of the exudative component with partial resolution of the granuloma was seen. After 6 months of ATT the entire fluid resolved, the granuloma showed regression [ Fig. 1d ] and the BCVA improved to 20/40.
Vascular endothelial growth factor (VEGF) expression is found to be increased at the site of an active tubercular CG. The up-regulation of VEGF occurs due to the induced production by the on site cytokines and/or as a secondary response to tissue hypoxia caused by inflammatory vascular obstruction. [1] The VEGF in turn accelerates angiogenesis and exudation at the target site which is the highly vascularized chorio-retinal juncture as in our case. Thus, anti-VEGF agents can promote resolution of exudation. The effective use of anti-VEGFs in tubercular granuloma have been documented before. [2, 3] It is difficult to say whether anti-VEGF assisted in resolution of the tubercular granuloma. However, it definitely seems to have enhanced the resolution of the exudative component. We also want to highlight the importance of follow up in cases of resolved CGs. Other than Choroidal neo-vascularization, recurrence can also be seen in large lesions.
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A 41-year-old male patient presented with floaters and decreased vision OD for 3 months. The vision was poor in OS since childhood. Systemic review revealed intermittent dyspnea, weight loss, and fatigability for 8 months.
Examination revealed a best corrected visual acuity (BCVA) of 6/24 right eye and 1/60 left eye. Anterior segments and intraocular pressure were normal in both the eyes. There was no RAPD. Left eye revealed unilateral hypermetropia of +8 diopters and amblyopia. Dilated fundus of right eye revealed minimal vitritis and a 2-disc diameter large optic This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com disc granuloma [ Fig. 1a ] obscuring the optic disc. Overlying tortuous blood vessels, few hard exudates, flame-shaped hemorrhages, sheathing of blood vessels, and ILM folds at the posterior pole were present. Swept source OCT (SSOCT) through the lesion demonstrated presence of elevated lesion with shadowing underneath [ Fig. 2a ]. In addition, vitreous attachment was seen attached to the surface of granuloma.
Complete blood count, liver, and kidney function tests were normal. Mantoux reading was 0 mm at 48 hrs. Serum angiotensin converting enzyme levels were elevated at 276 IU/L (8-52 IU/L). HRCT scan showed bilateral hilar lymphadenopathy. Transbronchial lung biopsy demonstrated presence of noncaseating granulomas, which were reticulin and acid-fast bacilli negative confirming pulmonary sarcoidosis. Patient was started on oral prednisolone 1mg/kg/day dose along with oral calcium supplements and proton pump inhibitors. Regression of granuloma was noted at two months [Figs.1b and 2b] and BCVA improved to 6/9 in right eye, which was maintained at 6-month follow up though the granuloma had increased in size [ Figs 1c and 2c] . Patient was on continued on 10 mg/day oral steroid. Since the patient was asymptomatic and vision was stable, we didn't consider increasing the steroid dosage or starting of immunomodulators.
Ocular sarcoidosis, the commonest type of extra thoracic sarcoidosis, has been reported in 21-80% cases.
[1] Optic nerve involvement (approximately in 1% cases) in sarcoidosis has been divided in to 5 different categories: optic disc edema secondary to posterior uveitis, optic disc edema secondary to raised intracranial pressure, optic neuritis, optic atrophy secondary
